News
September 17, 2020
New Test that Indicates Likelihood of Lupus Disease Flares is Now Available
A new test has been developed that can assess the likelihood of experiencing a lupus disease flare in the following three months or 12 weeks. The aiSLE™ DX Flare Risk Index is a blood test that measures blood changes against a set of laboratory blood-based biomarkers. If a person with lupus has a positive odds ratio, they are five times more likely to experience a disease flare than a healthy patient.
The test has the potential to help rheumatologists better manage lupus symptoms in people with the disease. To learn more about the test and how the test can help in your personal lupus disease management, please consult with your doctor. Learn about lab tests for lupus.
See More:
The latest from Inside Lupus Research
Study Offers New Data on COVID-19 and Lupus and Cautions Against Treatment Discontinuation
News
Scientists Advance Lupus Research, Identifying a New and Improved Way to Analyze Electronic Health Records
News
Researchers Report Insights to Guide Informed, Equitable and Sustainable Public Health Responses Beyond the COVID-19 Pandemic
News
Hydroxychloroquine May Pose Greater Eye-health Risk to People with Lupus Nephritis and Obesity
News
Get Inside Lupus Research Headlines Emailed to You
Sign up to get the latest lupus research delivered directly to your email.
Subscribe Now